scholarly article | Q13442814 |
P50 | author | Johannes S. Gach | Q55302516 |
Enrico Gratton | Q62059124 | ||
Marcus P Wong | Q88764877 | ||
Kuan-Ting Yu | Q89741673 | ||
Brijesh Sharma | Q89741674 | ||
Donald N Forthal | Q89741676 | ||
P2093 | author name string | Andrea Gorlani | |
Veronika Chromikova | |||
Margaux Bouzin | |||
P2860 | cites work | Fluorescence correlation spectroscopy. I. Conceptual basis and theory | Q56656039 |
Thermodynamic Fluctuations in a Reacting System—Measurement by Fluorescence Correlation Spectroscopy | Q21563722 | ||
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses | Q25708015 | ||
Electron tomography of HIV-1 infection in gut-associated lymphoid tissue | Q27331060 | ||
ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge | Q27342615 | ||
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding | Q27675486 | ||
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target | Q29547347 | ||
Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
Distribution and three-dimensional structure of AIDS virus envelope spikes | Q29617562 | ||
An improved method for differentiating cell-bound from internalized particles by imaging flow cytometry | Q30299956 | ||
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytes | Q30439425 | ||
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples | Q30498394 | ||
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1. | Q31132248 | ||
Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers | Q33444658 | ||
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1 | Q33725718 | ||
Which Antibody Functions are Important for an HIV Vaccine? | Q33772637 | ||
Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1. | Q33781055 | ||
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines | Q33794973 | ||
Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines | Q34057711 | ||
Fluorescence correlation spectroscopy: past, present, future | Q34114385 | ||
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity | Q34204325 | ||
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection | Q35156935 | ||
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms | Q35531167 | ||
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses | Q36118373 | ||
Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice | Q36484074 | ||
Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography | Q37682792 | ||
HIV-specific antibody immunity mediated through NK cells and monocytes | Q38160066 | ||
Functions of Antibodies | Q38535713 | ||
Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity | Q39307084 | ||
The direction of plasma membrane exchange between lymphocytes and accessory cells by trogocytosis is influenced by the nature of the accessory cell. | Q39749803 | ||
Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity | Q40117864 | ||
Photoinduced crosslinking of membrane proteins by fluorescein isothiocyanate | Q40208304 | ||
Functions of Antibodies. | Q41741684 | ||
Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection | Q41809363 | ||
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice | Q41919718 | ||
Fluorescence correlation spectroscopy. II. An experimental realization | Q43853123 | ||
Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice | Q45407549 | ||
FcgammaRIIa genotype predicts progression of HIV infection. | Q46017436 | ||
Fc receptor but not complement binding is important in antibody protection against HIV. | Q46545827 | ||
Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate | Q46775963 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P921 | main subject | phagocytosis | Q184726 |
P304 | page(s) | e1006793 | |
P577 | publication date | 2017-12-27 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis | |
P478 | volume | 13 |
Q63246407 | Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses |
Q59352288 | Antibody-dependent cellular cytotoxicity in HIV infection |
Q64263004 | Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1 |
Q91959282 | Moving the HIV vaccine field forward: concepts of protective immunity |
Q62487341 | Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1 |
Q92478519 | V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers |
Q93150656 | Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV |
Search more.